Thomas Smith
Stock Analyst at Leerink Partners
(1.5)
# 1697
Out of 5,218 analysts
102
Total ratings
30.16%
Success rate
20.90%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Q32 Bio | Downgrades: Market Perform | 68 9 | 3.69 | 143.9% | 2 | Dec 11, 2024 | |
Aclaris Therapeutics | Upgrades: Outperform | 2 7 | 3.23 | 116.72% | 7 | Nov 19, 2024 | |
Alumis | Initiates Coverage On: Outperform | 29 | 8.43 | 244.01% | 1 | Jul 23, 2024 | |
Cartesian Therapeuti... | Initiates Coverage On: Outperform | 39 | 18.67 | 108.89% | 1 | Apr 23, 2024 | |
Alpine Immune Scienc... | Downgrades: Market Perform | 42 65 | n/a | n/a | 2 | Apr 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 26 | 4.38 | 493.61% | 1 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 10 | 0.91 | 998.9% | 2 | Feb 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 33 | n/a | n/a | 2 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 20 | 7.15 | 179.72% | 1 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 30 17 | n/a | n/a | 3 | May 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 45 56 | n/a | n/a | 1 | Mar 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 430 435 | 606.64 | -28.29% | 3 | Mar 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 17 18 | n/a | n/a | 7 | Mar 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 36 | 64.78 | -44.43% | 1 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 12 7 | 0.72 | 872.22% | 3 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 9 7 | 1.11 | 530.63% | 4 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 14 21 | 26.32 | -20.21% | 6 | Feb 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 40 45 | 17.77 | 153.24% | 2 | Jan 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 6 | 4.17 | 43.88% | 1 | Nov 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 16 19 | n/a | n/a | 2 | Nov 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 30 20 | n/a | n/a | 4 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 5 6 | 6.54 | -8.26% | 2 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 9 5 | 1.13 | 342.48% | 3 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 46 77 | n/a | n/a | 1 | Oct 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 17 | 51.39 | -66.92% | 1 | Aug 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 55 60 | n/a | n/a | 5 | Aug 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 68 64 | 25.36 | 152.37% | 2 | Aug 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 66 70 | 20.58 | 240.14% | 5 | Aug 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 225 150 | n/a | n/a | 5 | Aug 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 50 29 | 7.7 | 276.62% | 5 | Jul 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 33 26 | 4.4 | 490.91% | 3 | Jun 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 13 12 | 1.04 | 1053.85% | 4 | May 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 18 12 | 46.98 | -74.46% | 2 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 15 10 | 3.82 | 161.78% | 4 | Apr 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 675 400 | 5.1 | 7743.14% | 2 | Mar 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 42 80 | 18.83 | 324.85% | 2 | Dec 8, 2020 |